Prevtec raises $2.5 mln to launch second vaccine in Europe
Canadian biotechnology company Prevtec Microbia Inc has secured $2.5 million in follow-on financing. Telesystem, Desjardins-Innovatech, Grupo Corporativo Fuertes and Echo Capital FIER Outaouais invested in the round. Prevtec, a developer of biological products for the prevention of diseases in food animals, said the funds raised will be used to launch a second swine vaccine in the European Union. The investment will also allow the company to add to its European team and manage demand from pig producers. Founded in 2001, Montréal-based Prevtec is led by President and CEO Michel Fortin.
21 March 2017•2 mins read
